Stock Market & Financial Investment News

News Breaks February 1, 2013 08:17 EDT MAPP MAP Pharmaceuticals downgraded to Neutral from Buy at Ladenburg Ladenburg downgraded MAP Pharmaceuticals citing Allergan's commencement of the agreed upon cash tender offer. The firm does not expect any competing bids to acquire MAP. News For MAPP From The Last 14 Days Check below for free stories on MAPP the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for MAPP Sign up for a free trial to see the rest of the stories you've been missing.